- October 19, 2026Source: New York Times (With Daniel Boffa, MD, MBA, FACS)
Why So Many People Still Are Not Screened for Lung Cancer
- October 14, 2026Source: CNN (With Daniel Bofffa, MD, MBA, FACS)
Pope Leo Diagnosed with Lung Cancer
- October 14, 2026Source: The New York Times (With Daniel Boffa, MD, MBA, FACS)
What to Know About Pope Leo's Lung Cancer Diagnosis
- October 12, 2026Source: WTNH-TV (With Daniel Boffa, MD, MBA, FACS)
Yale expert weighs in as Pope Leo XIV prepares for lung surgery
- September 18, 2026
Variety of Yale Cancer Center Research Highlights to be Presented at Radiation and Oncology Conference
- July 23, 2026Source: NBC Connecticut
Increased push for women over the age of 50 to get screened for lung cancer (with Daniel Boffa, MD)
- July 16, 2026
Understanding Financial Conflicts of Interest in Cancer Care and Research
- March 24, 2026
Alternative Treatments are Linked to Lower Breast Cancer Survival
- March 06, 2026Source: U.S. News & World Report (with Dr. Cary Gross and Dr. Olivia Lynch)
Racial Disparities Persist In Lung Cancer Treatment, Study Finds
- March 02, 2026
Gaps in Lung Cancer Treatment Persist, Yale Study Finds
- February 16, 2026
Dr. Xiao Wang Joins Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center
- January 08, 2026Source: JCO Podcast
Podcast: Association Between EOL SACT and Healthcare Utilization
The COPPER Center
Cancer Outcomes, Public Policy and Effectiveness Research Center
The mission of the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale is to improve cancer care and to decrease the burden of cancer on individual patients as well as society. Led by Cary P. Gross, MD, the Center is comprised of researchers and clinicians from across the Yale Schools of Medicine (Therapeutic Radiology, Surgical Oncology, Hematology/Medical Oncology, OB/GYN, Urology, and Internal Medicine) and Public Health (Epidemiology and Health Policy). We also provide training and mentorship to the next generation of cancer policy and outcomes researchers.
Goals
Copy Link
- Generate and disseminate new information that can improve the care and outcomes of patients with cancer.
- Develop and refine new research methods and data resources.
- Train and engage clinicians and researchers in the conduct of cancer-related outcomes, policy, and effectiveness research.
Center members currently collaborate on a wide spectrum of translational cancer research projects, employing expertise in clinical epidemiology, comparative effectiveness, and health services research across a variety of cancer types (breast, colon, head and neck, lung, prostate, bladder, and hematological malignancies) and clinical settings. COPPER investigators employ state of the art techniques to shed new light on the care and outcomes of older persons with cancer. The group has considerable experience analyzing large datasets, including cancer registry and administrative claims data, and collecting primary data.
In addition to COPPER's prominence in the scientific community, our research has been featured in high-impact lay publications such as The New York Times, The Wall Street Journal, and The Washington Post. Furthermore, our work has been cited in payer coverage decisions and medical society clinical guidelines. In 2019, COPPER research conducted in collaboration with Flatiron Health was selected for presentation at the ASCO Annual Meeting Plenary Session. For more information on this presentation and associated press coverage, please click here.
COPPER Contact
Copy Link
Cary P Gross, MD
Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases)